Diagnostic tests for primary immunodeficiency disorders: Classic and genetic testing

dc.contributor.authorKlangkalya N.
dc.contributor.authorFleisher T.A.
dc.contributor.authorRosenzweig S.D.
dc.contributor.correspondenceKlangkalya N.
dc.contributor.otherMahidol University
dc.date.accessioned2024-09-26T18:07:07Z
dc.date.available2024-09-26T18:07:07Z
dc.date.issued2024-09-01
dc.description.abstractPrimary immunodeficiency diseases encompass a variety of genetic conditions characterized by a compromised immune system and typically results in increased susceptibility to infection. In fact, they also manifest as autoimmunity, autoinflammation, atopic diseases, and malignancy. Currently, the number of recognized monogenic primary immunodeficiency disorders is set at ∼500 different entities, owing to the exponential use of unbiased genetic testing for disease discovery. In addition, the prevalence of secondary immunodeficiency has also been on the rise due to the increased use of immunosuppressive drugs to treat diseases based on immune dysregulation, an increase in the number of individuals undergoing hematopoietic stem cell transplantation, and other chronic medical conditions, including autoimmunity. Although the clinical symptoms of immunodeficiency disorders are broad, an early diagnosis and tailored management strategies are essential to mitigate the risk of infections and prevent disease-associated morbidity. Generally, the medical history and physical examination can provide useful information that can help delineate the possibility of immune defects. In turn, this makes it feasible to select focused laboratory tests that identify immunodeficiency disorders based on the specific immune cells and their functions or products that are affected. Laboratory evaluation involves quantitative and functional classic testing (e.g., leukocyte counts, serum immunoglobulin levels, specific antibody titers in response to vaccines, and enumeration of lymphocyte subsets) as well as genetic testing (e.g., individual gene evaluation via Sanger sequencing or unbiased evaluation based on next-generation sequencing). However, in many cases, a diagnosis also requires additional advanced research techniques to validate genetic or other findings. This article updates clinicians about available laboratory tests for evaluating the immune system in patients with primary immunodeficiency disorders. It also provides a comprehensive list of testing options, organized based on different components of host defense.
dc.identifier.citationAllergy and asthma proceedings Vol.45 No.5 (2024) , 355-363
dc.identifier.doi10.2500/aap.2024.45.240051
dc.identifier.eissn15396304
dc.identifier.pmid39294902
dc.identifier.scopus2-s2.0-85204417669
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/101359
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleDiagnostic tests for primary immunodeficiency disorders: Classic and genetic testing
dc.typeReview
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85204417669&origin=inward
oaire.citation.endPage363
oaire.citation.issue5
oaire.citation.startPage355
oaire.citation.titleAllergy and asthma proceedings
oaire.citation.volume45
oairecerif.author.affiliationFaculty of Medicine Ramathibodi Hospital, Mahidol University
oairecerif.author.affiliationNational Institutes of Health (NIH)

Files

Collections